Page last updated: 2024-10-31

minoxidil and Loose Anagen Hair Syndrome

minoxidil has been researched along with Loose Anagen Hair Syndrome in 3 studies

Minoxidil: A potent direct-acting peripheral vasodilator (VASODILATOR AGENTS) that reduces peripheral resistance and produces a fall in BLOOD PRESSURE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p371)
minoxidil : A pyrimidine N-oxide that is pyrimidine-2,4-diamine 3-oxide substituted by a piperidin-1-yl group at position 6.

Loose Anagen Hair Syndrome: Benign childhood alopecia that improves spontaneously with aging. It is characterized by anagen hairs (misshapen hair bulbs and absent inner and outer root sheaths), thin, and sparse hairs that pulls out easily.

Research Excerpts

ExcerptRelevanceReference
"To fully understand hair loss during childhood, a basic comprehension of normal hair growth is necessary."2.52Hair loss in children. ( Alves, R; Grimalt, R, 2015)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Jerjen, R1
Koh, WL1
Sinclair, R2
Bhoyrul, B1
Cranwell, WC1
Alves, R1
Grimalt, R1

Reviews

1 review available for minoxidil and Loose Anagen Hair Syndrome

ArticleYear
Hair loss in children.
    Current problems in dermatology, 2015, Volume: 47

    Topics: Adrenal Cortex Hormones; Alopecia; Alopecia Areata; Child; Child, Preschool; Diagnosis, Differential

2015

Other Studies

2 other studies available for minoxidil and Loose Anagen Hair Syndrome

ArticleYear
Low-dose oral minoxidil improves global hair density and length in children with loose anagen hair syndrome.
    The British journal of dermatology, 2021, Volume: 184, Issue:5

    Topics: Child; Hair; Humans; Loose Anagen Hair Syndrome; Minoxidil

2021
Loose anagen hair syndrome: Treatment with systemic minoxidil characterised by marked hair colour change.
    The Australasian journal of dermatology, 2018, Volume: 59, Issue:4

    Topics: Administration, Oral; Child; Dose-Response Relationship, Drug; Drug Administration Schedule; Female;

2018